Navigation Links
Orexigen(R) Therapeutics to Speak at BIO CEO & Investor Conference
Date:2/4/2009

SAN DIEGO, Feb. 4 /PRNewswire-FirstCall/ -- Orexigen(R) Therapeutics, Inc. (Nasdaq: OREX), a biopharmaceutical company focused on the treatment of obesity, today announced that the Company will be speaking at the 11th Annual BIO CEO & Investor Conference. The details are as follows:

    Corporate Presentation:
    Date:  Monday, February 9, 2009
    Time:  3:45 p.m. - 4:15 p.m. Eastern
    Location: Waldorf Astoria, Astor Room, New York
    Speaker: Graham Cooper, Chief Financial Officer

    Panel Discussion:
    Feeding the Need for New Treatments in Obesity
    Date:  Monday, February 9, 2009
    Time:  11:00 a.m. - 12:10 p.m. Eastern
    Location: Waldorf Astoria, East Foyer, New York
    Speaker: Dr. Dennis Kim, Senior Vice President, Corporate Development

About Orexigen Therapeutics

Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead combination product candidates are Contrave, which is in Phase 3 clinical trials, and Empatic, which is in the later stages of Phase 2 clinical development. Each product candidate is designed to act on a specific group of neurons in the central nervous system with the goal of achieving appetite suppression and sustained weight loss. Further information about the company can be found at http://www.orexigen.com.


'/>"/>
SOURCE Orexigen Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Orexigen(R) Therapeutics Announces First of Four Phase 3 Trials of Contrave(R) Meets Co-Primary and Key Secondary Endpoints
2. Orexigen(R) Therapeutics Issued a Key Fourth U.S. Patent on Contrave(R)
3. Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results
4. Orexigen(R) Therapeutics Initiates First Clinical Trial of OREX-003 for the Mitigation of Antipsychotic-Associated Weight Gain
5. Orexigen(R) Therapeutics Appoints Dennis Kim, M.D., as Senior Vice President, Head of Obesity and Metabolic Disorders
6. Orexigen(R) Therapeutics to Present at Upcoming Investor Conferences
7. Orexigen(R) Therapeutics Schedules Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2008
8. OREXIGEN(R) Therapeutics Receives Notice of Allowance for U.S. Patent Covering the Composition of Matter in OREX-003
9. Lentigen and Expression Therapeutics Sign Hemophilia Co-Development Agreement
10. Omnitura Therapeutics Announces Private Placement Financing
11. Amicus Therapeutics Announces Fourth Quarter and Year End 2008 Financial Results Release Date
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Texas (PRWEB) September 22, 2014 This ... state of the M-Phenylenediamine (mPDA) industry in Global ... the industry, including definitions, applications and industry chain structure. ... provided with a focus on history, developments, trends and ... international and Chinese situation is also offered. , The ...
(Date:9/22/2014)... 22, 2014 Research and Markets ... Chinese Microcrystalline Cellulose Industry Report 2014" report to ... Microcrystalline Cellulose Industry Report 2014 is a professional and ... microcrystalline cellulose industry with a focus on the Chinese ... of the industry including definitions, classifications, applications and industry ...
(Date:9/22/2014)... 2014  WIRB-Copernicus Group (WCG), the world,s largest ... clinical research, announced today that its Western Institutional ... by the Association for the Accreditation of Human ... safeguards for clinical research participants. WCG ... Ph.D., commented, "It is of utmost importance to ...
(Date:9/21/2014)... Switzerland have succeeded in observing the "forbidden" infrared ... time. These extremely weak spectra offer perspectives for ... also contribute to the development of molecular clocks ... the scientific journal Nature Physics . , ... and light, is probably the most important method ...
Breaking Biology Technology:m-Phenylenediamine Industry: mPDA Global & China Trend Analysis Now Available at ReportsnReports.com 2m-Phenylenediamine Industry: mPDA Global & China Trend Analysis Now Available at ReportsnReports.com 3Global and Chinese Microcrystalline Cellulose Industry Report 2014 2Western IRB (WIRB) Awarded AAHRPP Reaccreditation 2Uncovering the forbidden side of molecules 2
... China, Nov. 9, 2010 /PRNewswire-Asia-FirstCall/ -- ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so we need ...
... With Pfizer -- CHARLOTTESVILLE, Virginia, November 9, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... var s = ,; var first_result; // Results are keyed by longUrl, so we need to grab the first ...
... Nov. 9, 2010 Verenium Corporation (Nasdaq: ... of high-performance industrial enzyme solutions, today announced that Janet ... the upcoming Jefferies 10th Global Clean Technology Conference.  The ... on Tuesday, November 16, 2010 and will take place ...
Cached Biology Technology:China Biologic Products Schedules Conference Call to Discuss Third Quarter 2010 Results 2China Biologic Products Schedules Conference Call to Discuss Third Quarter 2010 Results 3China Biologic Products Schedules Conference Call to Discuss Third Quarter 2010 Results 4China Biologic Products Schedules Conference Call to Discuss Third Quarter 2010 Results 5China Biologic Products Schedules Conference Call to Discuss Third Quarter 2010 Results 6China Biologic Products Schedules Conference Call to Discuss Third Quarter 2010 Results 7China Biologic Products Schedules Conference Call to Discuss Third Quarter 2010 Results 8Biovista Announces a Drug Repositioning Collaboration With Pfizer 2Biovista Announces a Drug Repositioning Collaboration With Pfizer 3Biovista Announces a Drug Repositioning Collaboration With Pfizer 4Biovista Announces a Drug Repositioning Collaboration With Pfizer 5Biovista Announces a Drug Repositioning Collaboration With Pfizer 6Biovista Announces a Drug Repositioning Collaboration With Pfizer 7Biovista Announces a Drug Repositioning Collaboration With Pfizer 8Verenium to Present at Jefferies 10th Global Clean Technology Conference 2Verenium to Present at Jefferies 10th Global Clean Technology Conference 3
(Date:9/22/2014)... could be much more useful in homes, if they ... see the world with cameras and lasers, which have ... are hidden in clutter. A complementary way robots can ... of small ultra-high frequency radio-frequency identification (UHF RFID) tags. ... an RFID-equipped robot to search a room for the ...
(Date:9/22/2014)... 7,000 geoscientists will gather in Vancouver, British Columbia, Canada, ... America,s 126th Annual Meeting & Exposition on 19-22 October ... transportation of crude oil, earthquake prediction problems, and how ... and Tribulations of Life on an Active Subduction Zone, ... , A broad range of topics will be presented ...
(Date:9/21/2014)... Diego, have developed a program that predicts the placement ... based on sequences of DNA. They describe their analysis ... cells in a paper published in Nature Methods ... have the same blueprint, the same DNA, although they ... the report. "Skin cells protect, nerve cells send signals, ...
Breaking Biology News(10 mins):New RFID technology helps robots find household objects 2New RFID technology helps robots find household objects 3Geoscience topics in the spotlight -- Vancouver, BC 2Geoscience topics in the spotlight -- Vancouver, BC 3Geoscience topics in the spotlight -- Vancouver, BC 4Geoscience topics in the spotlight -- Vancouver, BC 5Program predicts placement of chemical tags that control gene activity 2
... Genomics Consortium’s (IGC) Expression Project for Oncology (expO) ... 60 tumor specimens, completing the initial phase of ... dedicated to standardized gene expression data. The clinically ... through the National Center for Biotechnology Information web ...
... Medical Center implanted Artificial Silicon Retina (ASR) microchips in ... caused by retinitis pigmentosa (RP). The implant is a ... inch thick, less than the thickness of a human ... The fifth patient is scheduled for a later date. ...
... in a taste receptor gene influences taste sensitivity of ... preferences and food selection, report a team of researchers ... genes, age and culture also contribute to taste preferences, ... findings may help to explain why some children are ...
Cached Biology News:Expression Project for Oncology (expO) completes first phase of standardized gene expression analyses 2Expression Project for Oncology (expO) completes first phase of standardized gene expression analyses 3Ophthalmologists implant five patients with artificial silicon retina microchip 2Ophthalmologists implant five patients with artificial silicon retina microchip 3Children's taste sensitivity and food choices influenced by taste gene 2Children's taste sensitivity and food choices influenced by taste gene 3
... for use as a wash buffer for Michels ... is useful for transportation of specimens (such as ... Samples may remain in Transport Fluid for ... Michels Transport Fluid is not a fixative and ...
... use with 96- or 384-well PCR plates Dimples ... location on 96-tube plates End tabs on Thermo-Mat™ ... plate* Efficient sealing is achieved with either Thermo-Mat™ ... or clip-down hot lid thermal cyclers Fully autoclavable ...
... TUNEL-based assay kit provides complete components including ... detection of DNA fragmentation in cultured cells ... in the procedure provides greater sensitivity than ... analyzed by flow cytometry. The kit works ...
... Buffer is a unique alternative to ... (TRIS acetate-EDTA) electrophoresis buffers. Bionic Buffer ... rapid running times, and high-resolution band ... gel electrophoresis after dilution to working ...
Biology Products: